Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate

Biochemistry. 2008 May 13;47(19):5312-6. doi: 10.1021/bi8001055. Epub 2008 Apr 19.

Abstract

The intrinsic resistance of Mycobacterium tuberculosis to the beta-lactam class of antibiotics arises from a chromosomally encoded, extended spectrum, class A beta-lactamase, BlaC. Herein, we report the X-ray crystallographic structure of BlaC inhibited with clavulanate at a resolution of 1.7 A with an R-factor value of 0.180 and R-free value of 0.212 for the m/ z +154 clavulanate-derived fragment observed in the active site. Structural evidence reveals the presence of hydrogen bonds to the C1 carbonyl along with a coplanar arrangement of C1, C2, C3, and N4, which favors enolization to generate a trans-alpha,beta-eneamine, stabilizing the +154 adduct from hydrolysis. The irreversible inhibition of BlaC suggests that treatment of M. tuberculosis with a combination of a beta-lactam antibiotic and clavulanate may lead to rapid bactericidal activity.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Clavulanic Acid / chemistry*
  • Clavulanic Acid / metabolism*
  • Clavulanic Acid / pharmacology
  • Crystallography, X-Ray
  • Models, Molecular
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / enzymology*
  • Mycobacterium tuberculosis / genetics
  • Protein Binding
  • Protein Structure, Tertiary
  • beta-Lactamase Inhibitors
  • beta-Lactamases / chemistry*
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • beta-Lactamase Inhibitors
  • Clavulanic Acid
  • beta-Lactamases

Associated data

  • PDB/3CG5